Helius Total Debt To Capitalization from 2010 to 2024

HSDT Stock  USD 4.98  0.10  1.97%   
Helius Medical Total Debt To Capitalization yearly trend continues to be comparatively stable with very little volatility. Total Debt To Capitalization is likely to outpace its year average in 2024. From the period from 2010 to 2024, Helius Medical Total Debt To Capitalization quarterly data regression had r-value of  0.78 and coefficient of variation of (162.90). View All Fundamentals
 
Total Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.02368093
Current Value
0.0249
Quarterly Volatility
0.10463376
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many exotic indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
This module can also supplement various Helius Medical Technical models . Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Total Debt To Capitalization Growth Pattern

Below is the plot of the Total Debt To Capitalization of Helius Medical Technologies over the last few years. It is Helius Medical's Total Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
Total Debt To Capitalization10 Years Trend
Slightly volatile
   Total Debt To Capitalization   
       Timeline  

Helius Total Debt To Capitalization Regression Statistics

Arithmetic Mean(0.06)
Geometric Mean0.06
Coefficient Of Variation(162.90)
Mean Deviation0.1
Median(0.16)
Standard Deviation0.10
Sample Variance0.01
Range0.2541
R-Value0.78
Mean Square Error0
R-Squared0.61
Significance0.0006
Slope0.02
Total Sum of Squares0.15

Helius Total Debt To Capitalization History

2024 0.0249
2023 0.0237
2022 0.0133
2021 2.66E-4
2020 0.023
2018 0.0984

About Helius Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Helius Medical income statement, its balance sheet, and the statement of cash flows. Helius Medical investors use historical funamental indicators, such as Helius Medical's Total Debt To Capitalization, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may use each financial statement separately, they are all related. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Helius Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Helius Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Helius Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Debt To Capitalization 0.02  0.02 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Helius Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Helius Medical's short interest history, or implied volatility extrapolated from Helius Medical options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Helius Medical Techn is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Helius Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Helius Medical Technologies Stock. Highlighted below are key reports to facilitate an investment decision about Helius Medical Technologies Stock:
Check out the analysis of Helius Medical Correlation against competitors.
Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Helius Stock analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(14.56)
Revenue Per Share
1.059
Quarterly Revenue Growth
(0.53)
Return On Assets
(0.61)
Return On Equity
(1.69)
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.